gms | German Medical Science

Deutscher Rheumatologiekongress 2023

51. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh)
37. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh)
33. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)

30.08. - 02.09.2023, Leipzig

Value of Small Fiber Neuropathy in fibromyalgia patients in a rheumatological setting

Meeting Abstract

  • Styliani Tsiami - Rheumazentrum Ruhrgebiet Herne, Herne; Ruhr-Universität Bochum, Bochum
  • Elena Enax-Krumova - Ruhr-Universität Bochum, Bochum; Neurologische Klinik Universitätsklinikum Bergmannsheil Bochum, Bochum
  • Dietrich Sturm - Agaplesion Bethesda – Krankenhaus, Wuppertal, Klinik für Neurologie, Wuppertal
  • Matthias Vorgerd - Ruhr-Universität Bochum, Bochum; Neurologische Klinik Universitätsklinikum Bergmannsheil Bochum, Bochum
  • Björn Bühring - Krankenhaus St. Josef, Wuppertal, Klinik für Internistische Rheumatologie, Wuppertal
  • Jürgen Braun - Rheumazentrum Ruhrgebiet Herne, Herne; Ruhr-Universität Bochum, Bochum
  • Xenofon Baraliakos - Rheumazentrum Ruhrgebiet Herne, Herne; Ruhr-Universität Bochum, Bochum

Deutsche Gesellschaft für Rheumatologie. Deutsche Gesellschaft für Orthopädische Rheumatologie. Gesellschaft für Kinder- und Jugendrheumatologie. Deutscher Rheumatologiekongress 2023, 51. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 37. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), 33. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR). Leipzig, 30.08.-02.09.2023. Düsseldorf: German Medical Science GMS Publishing House; 2023. DocVS.07

doi: 10.3205/23dgrh239, urn:nbn:de:0183-23dgrh2394

Veröffentlicht: 30. August 2023

© 2023 Tsiami et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Introduction: Small fiber neuropathy (SFN), a polyneuropathy (PNP) affecting A-delta and C-fibers has been described in patients with fibromyalgia (FM). Different patterns of small fiber damage may characterize distinct subtypes of FM. We aimed to investigate the value of detecting different degrees of SFN in patients diagnosed with FM

Methods: Consecutive patients who were treated for pain exacerbation of FM at a university specialized tertiary center were included in the study after informed consent. Patients had to fulfil the 2016 ACR diagnostic criteria for FM and other inflammatory rheumatic musculoskeletal diseases (RMD) were excluded. The rheumatological therapy included pain pharmacotherapy, balneophysical treatment, physiotherapy and occupational therapy. All patients underwent a careful rheumatologic and neurologic physical clinical examination including a Schirmer-Test for dry eyes and were asked to fill out questionnaires, in which data on pain, depression, neuropathic symptoms, sleep quality, daytime sleepiness, fatigue, and quality of life were assessed. Thereafter small fiber tests were performed in the neurologic department including a skin punch biopsy on the upper and lower leg and a corneal confocal microscopy (CCM).

Results: Overall, 93 patients (86 females, 92.5%, mean age 54±10.1, mean disease duration 4.9±5.3 years) were included, 25 received anticonvulsants (26.9%) and 15 opioids (16.1%) for pain treatment. Intraepidermal nerve fiber density (IENFD) as detected by skin biopsy was reduced in 58 patients (62.4%), 43 of whom (74.1%) had reduced IENFD at both proximal and distal sites. CCM showed pathologic findings in 18 patients with reduced IENFD at any site (31%) and in 8 with normal IENFD (22.9%), with dry eyes being present in 13 (22.4%) and 6 (17.1%) of those patients, respectively. There was no difference in pain, depression, neuropathic symptoms, sleep quality, daytime sleepiness, fatigue, or quality of life scores between groups (Table 1 [Tab. 1]).

Conclusion: In this FM population with high disease burden and indication for inpatient therapy, small fiber pathology as found by skin biopsies and CCM was present in more than two third of the FM patients suggesting that there are subgroups. However, there were no significant clinical differences between patients with and without SFN.